Table 3. Characteristics and Outcomes in Patients With Perfusion Defects and Wall Motion Abnormality
DemographicsRisk FactorsLVEFMVP, No. Positive SegmentsWM, No. Positive SegmentsAngiography/RevascularizationOutcome
49 maleHTN, smoking60%33No significant epicardial CADNo adverse outcome
55 maleHTN, smoking55%662 vessel disease, underwent CABGNo adverse outcome
66 femaleHTN, Hyperlipidemia73%3NoneNo angiography performedNo adverse outcome
50 femaleHTN, DM60%55No significant epicardial CADNo adverse outcome
52 maleHyperlipidemia60%22No significant epicardial CADNo adverse outcome
62 maleHTN, DM, smoker, CAD70%442 vessel disease, PCI to LAD and RCANon cardiovascular death
56 femaleHTN, DM, CAD60%3NoneObstructive LAD disease, LIMA to LADNon cardiovascular death
62 femaleNone61%22No significant epicardial CADNo adverse outcome
52 maleNone65%2NoneNo significant epicardial CADNo adverse outcome
57 maleHTN, smoker, CAD60%222 vessel disease, CABG with LIMA to LAD and SVG to LCXNon cardiovascular death
68 femaleHTN60%33No significant epicardial CADNonfatal MI
58 maleHTN, DM, smoker, CAD70%33LCX disease, PCI of mid‐ LCXCardiovascular death I
69 femaleHTN, CAD67%44Multivessel disease, CABG (of the 18 patients with abnormal DSPE)No adverse outcome
54 maleDM50%2NoneNo angiography performedCardiovascular death
62 maleDM, smoker54%2NoneNo angiography performedNo adverse outcome
HTN, hyperlipidemia60%22LAD and diagonal disease, PCI of LAD and DiagonalNo adverse outcome
61 maleHTN, DM72%33No angiography performedNo adverse outcome
70 femaleHTN, DM65%22No significant epicardial CADNo adverse outcome
  • Patients with abnormal MVP during dobutamine stress, with subsequent angiographic results and clinical outcome. CABG indicates coronary artery bypass grafting; CAD, coronary artery disease; DM, diabetes mellitus; DSPE, dobutamine stress perfusion echocardiography; HTN, hypertension; LAD, left anterior descending artery; LCX, left circumflex artery; LIMA, left internal mammary artery grafting; LVEF, left ventricular ejection fraction; MI, myocardial infarction; MVP, microvascular perfusion; PCI, percutaneous coronary intervention; RCA, right coronary artery; SVG, saphenous vein graft; WM, wall motion.